2025 HCPCS code J2597
Injection, desmopressin acetate, per 1 mcg.
Applicable modifiers provide additional information about the circumstances of the drug's administration and may affect reimbursement.
Medical necessity must be established by documenting the underlying medical condition for which the medication is being administered. This includes symptoms, diagnostic test results, and failed attempts at other treatments if any.
The clinician's responsibility includes determining the appropriate dosage, route of administration (intravenous or subcutaneous), and monitoring the patient's response to the medication. They should also educate the patient about potential side effects and follow-up care.
In simple words: This code covers the cost of the medication desmopressin acetate, which is a man-made version of a hormone that helps control the body's water balance. It's used to treat conditions like bed-wetting and excessive thirst. This code is for the medication itself, not the process of giving the injection.
Desmopressin acetate is a synthetic form of the human hormone vasopressin that regulates blood flow, blood pressure, and water balance. It's used to treat conditions like bed-wetting and excessive thirst and urination. One unit of this code represents 1 mcg of the drug. It's administered via injection, either intravenously or subcutaneously. This code represents only the drug itself, not its administration.
Example 1: A 7-year-old patient with primary nocturnal enuresis (bed-wetting) is prescribed desmopressin acetate to reduce nighttime urine production., A patient with central diabetes insipidus, resulting in excessive thirst and urination, receives desmopressin acetate injections to regulate their fluid balance., A patient diagnosed with mild hemophilia A or von Willebrand disease is given desmopressin acetate to shorten the activated partial thromboplastin time and bleeding time prior to a minor surgery
Documentation should include the diagnosis necessitating desmopressin acetate, the dosage administered, the route of administration, the patient's response to the medication, and any related adverse events.
** This is a generic drug. Brand names include DDAVP and Stimate. Always check the latest HCPCS coding guidelines and individual payer policies for updated information and coverage rules. As of December 10, 2024, this information is current, but it is essential to verify with the latest coding resources for any updates.
- Payment Status: Active
- Specialties:Pediatrics, Endocrinology, Hematology
- Place of Service:Office, Inpatient Hospital, Outpatient Hospital